Search results
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 2 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 19% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX). But if...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 7 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Why BioNTech Was a Sickly Stock This Week
Motley Fool· 1 year agoWhat happened BioNTech (NASDAQ: BNTX), a company that rose to great prominence and a high stock price during the coronavirus pandemic, wasn't much of a...
Do Options Traders Know Something About BioNTech (BNTX) Stock We Don't?
Zacks via Yahoo Finance· 2 years agoInvestors in BioNTech SE BNTX need to pay close attention to the stock based on moves in the options...
BioNTech SE Sponsored ADR (BNTX) Stock Moves -0.79%: What You Should Know
Zacks via Yahoo Finance· 1 year agoIn the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $137.53, marking a -0.79%...
Why BioNTech Stock Climbed Today
Motley Fool· 2 years agoShares of BioNTech (NASDAQ: BNTX) rose on Monday, following the release of the biotechnology company's first-quarter financial results. As of 2 p.m. ET,...
BioNTech SE's (NASDAQ:BNTX) largest shareholders are private equity firms with 43% ownership,...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The considerable ownership by private equity firms in BioNTech indicates that they...
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
Investor's Business Daily· 9 months agoGerman biotech BioNTech said Monday it's trimming drug development costs amid plummeting Covid...
BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics
Zacks via Yahoo Finance· 1 year agoBioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small...